Renaissance Technologies
LXEO icon

Renaissance Technologies’s Lexeo Therapeutics LXEO Stock Holding History

Renaissance Technologies’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
+250,365
New +$1.35M ﹤0.01% 2238
2026
Q1 		– Sell
-217,772
Closed -$2.16M – 3510
2025
Q4 		$2.16M Buy
217,772
+68,472
+46% +$625K ﹤0.01% 1814
2025
Q3 		$991K Buy
149,300
+43,100
+41% +$208K ﹤0.01% 2485
2025
Q2 		$427K Buy
106,200
+85,900
+423% +$282K ﹤0.01% 2913
2025
Q1 		$70.4K Buy
+20,300
New +$89.9K ﹤0.01% 3241
2024
Q2 		– Sell
-14,576
Closed -$229K – 3778
2024
Q1 		$229K Buy
+14,576
New +$228K ﹤0.01% 3184

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies's LXEO Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 250,365 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #2238 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in LXEO as recently as Q4 2025.

Renaissance Technologies first reported a position in LXEO in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.16M in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Renaissance Technologies held 250,365 shares of Lexeo Therapeutics worth $1.17M as of Q2 2026.
  • Lexeo Therapeutics was a new Renaissance Technologies position in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2238 holding.
  • Renaissance Technologies first reported a position in Lexeo Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Renaissance Technologies's Lexeo Therapeutics position peaked at $2.16M in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.